Plus Therapeutics earnings were -$19.0M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest PSTV earnings report on Jun 30, 2025 announced Q2 2025 earnings of $5.2M, down 129.6% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PSTV reported annual earnings of -$13.0M, with -2.5% growth.
What were Plus Therapeutics's earnings last quarter?
On PSTV's earnings call on Invalid Date, Plus Therapeutics (NASDAQ: PSTV) reported Q2 2025 earnings per share (EPS) of $0.02, up 104.44% year over year. Total PSTV earnings for the quarter were $5.15 million. In the same quarter last year, Plus Therapeutics's earnings per share (EPS) was -$0.45.
As of the last Plus Therapeutics earnings report, Plus Therapeutics is currently losing money. Plus Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$19.03 million, a 43.82% increase year over year.
What was PSTV's earnings growth in the past year?
As of Plus Therapeutics's earnings date in Invalid Date, Plus Therapeutics's earnings has grown year over year. PSTV earnings in the past year totalled -$19.03 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.